HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Sven Beholz Wolfgang Konertz Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Beholz, S. Articles by Konertz, W. Search for Related Content PubMed PubMed Citation Articles by Beholz, S. Articles by Konertz, W. Related Collections Valve disease

Continuous Suture Technique for Freedom Stentless Valve: Reduced Crossclamp Time

Department of Cardiovascular Surgery, Charité–University Medicine Berlin, Berlin, Germany

For reprint information contact: Sven Beholz, PhD Tel: 49 30 450 522 196 Fax: 49 30 450 522 921 Email: sven.beholz{at}charite.de, Department of Cardiovascular Surgery, Charité-University Medicine Berlin, Luisenstr. 65, Berlin 10117, Germany.

The Pericarbon Freedom stentless valve has shown excellent hemodynamics. A continuous suture technique at the inflow site may reduce cardiopulmonary bypass and crossclamp times and affect postoperative hemodynamics. In a prospective case-matched study, interrupted and continuous suture line techniques were used in 68 and 71 patients, respectively. Isolated valve replacement was performed in 70.4% of the continuous suture group and 67.6% of the interrupted suture group. Hemodynamic data were obtained by echocardiography (mean and peak gradients, regurgitation) at discharge and after 1 year. Overall mortality was 5.0% and due to non-valve-related causes. Bypass and crossclamp times were shorter by 22.4 and 20.6 min, respectively, in the continuous suture group. The suture technique at the inflow site did not result in significant differences in the mean (11.8 ± 6.3 vs. 12.5 ± 6.2 mm Hg) or peak gradients (21.0 ± 9.6 vs. 22.0 ± 10.9 mm Hg), or degree of regurgitation. Follow-up showed a further decrease in the gradients.

This article has been cited by other articles:

				C. Yerebakan, A. Kaminski, B. Westphal, G. Kundt, M. Ugurlucan, G. Steinhoff, and A. Liebold Thrombocytopenia after aortic valve replacement with the Freedom Solo stentless bioprosthesis Interactive CardioVascular and Thoracic Surgery, August 1, 2008; 7(4): 616 - 620. [Abstract] [Full Text] [PDF]

				A. D'Onofrio, S. Auriemma, P. Magagna, A. Favaro, A. Cannarella, C. Piccin, M. Bilotta, N. Abbiate, N. Lamascese, and A. Fabbri Aortic valve replacement with the Sorin Pericarbon Freedom stentless prosthesis: 7 years' experience in 130 patients J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 491 - 495. [Abstract] [Full Text] [PDF]